Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2026-09-14 18:55:01 ET · period of report 2026-09-10 · accession 0001628280-26-061940 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 18:55 | 2026-09-10 | BMRN | Plenge Robert M | Dir | A - Grant | $0.00 | +6,140 | 6,140 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-10 | A | A | 6,140 | $0.00 | 6,140 | D | — | — | (F1) Restricted stock units granted on September 10, 2026. Price not applicable. |